lobbying_activities: 2303077

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2303077	958e6ab2-2fcc-4534-abcf-9275d3364fbc	Q2	THE D MAJOR GROUP	401103162	ALLERGAN INC (FORMERLY ACTAVIS INC )	2019	second_quarter	CPT	Promote inter partes reform proposals -- specifically, including the Hatch Waxman Integrity Act (S. 344 and H.R. 990). Also, monitor patent reform proposals such as S. 1416, The Affordable Prescriptions for Patients Act of 2019; and S. 440, The PACED Act.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2019-07-14T22:10:17.490000-04:00